Publications Repository

Publications Repository

Search 
  •   Home
  • ICR Divisions
  • Search
  • Home
  • ICR Divisions
  • Search
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search

Show advanced filtersHide advanced filters

Filters

Use filters to refine the search results.

Now showing items 1-10 of 16

  • Sort Options:
  • Relevance
  • Issue date (newest)
  • Issue date (oldest)
  • Results Per Page:
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
Thumbnail

BCL6 INHIBITORS 

Meniconi, M
Thumbnail

HETEROARYL INHIBITORS OF PAD4 

Meniconi, M (2018-03-15)
Thumbnail

ALDEHYDE COMPOUNDS AS INHIBITORS OF DUST MITE GROUP 1 PEPTIDASE ALLERGEN AND THEIR USE 

Newton, G; Robinson, C; Jenkins, K (2012-01-12)
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aldehyde compounds of the following formula (A) (for convenience, collectively referred to herein as "ALD ...
Thumbnail

Preparation of tyrosine amide derivatives as Rho-​kinase inhibitors 

Bhalay, G (2018-08-02)
The invention relates to compds. of formula I and pharmaceutically acceptable salts and solvates thereof (wherein X1 and X2 are independently CH and N; p = 1 - 3; each R when present is halo; R0 and R1 are independently ...
Thumbnail

PYRIMIDINE COMPOUNDS AS INHIBITORS OF PROTEIN KINASES IKK EPSILON AND/OR TBK-1, PROCESSES FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 

Newton, G; Stewart, M (2012-01-26)
Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases IKKe and/or TBK-1 : in which: R1 represents an aliphatic heterocyclyl ...
Thumbnail

5-(PYRIMIDIN-4-YL)-2-(PYRROLIDIN-1-YL)NICOTINONITRILE COMPOUNDS AS IKKE, TBK1 AND/OR SIK2 KINASES INHIBITORS 

Newton, G (2018-08-30)
The invention provides compounds of formula (I) wherein R is −CH3 or −CH2CH3 and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful in the treatment of diseases or disorders mediated by IKKE, ...
Thumbnail

Heteroaryl derivatives as sepiapterin reductase inhibitors 

Meniconi, M
Thumbnail

MAP4K4 Inhibitors 

Newton, G; Schneider, M (2020-06-11)
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method ...
Thumbnail

PYRIMIDINE COMPOUNDS USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY IKKE AND/OR TBK1 MECHANISMS 

Newton, G; Stewart, M (2014-08-28)
Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases associated with aberrant activity of the protein kinases &Igr;&Kgr;&Kgr;&egr; and/or TBK-1 in which one of V and W is N, and ...
Thumbnail

(2-carboxamido)(3-amino)thiophene compounds 

Newton, G; Wynne, G; Keily, J; Smyth, D; Crew, A (2005-09-27)
Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein R1 is R2 is and R3 is C 0-4 alkyl, are useful in the treatment of cancer.
  • «
  • 1
  • 2
  • »

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis communityBy issue dateAuthorsTitlesPublication Types

Discover

AuthorNewton, Gary (9)Meniconi, Mirco (6)Bhalay, Gurdip (1)Lord, Christopher (1)SubjectKinase (7)Allergy (2)Cancer (2)Cardiovascular (2)Inflammation (2)... View MoreDate Issued2010 - 2020 (10)2005 - 2009 (1)Publication Type
Patent (16)
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.